Holen Sie sich die Stockscreener-App
20.95
2.15%
0.44
Schlusskurs vom Vortag:
$20.51
Offen:
$20.42
24-Stunden-Volumen:
10,261
Relative Volume:
0.32
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.43%
1M Leistung:
+3.56%
6M Leistung:
-7.42%
1J Leistung:
-9.55%
1-Tages-Spanne:
$20.39
$20.97
1-Wochen-Bereich:
$20.38
$20.97
52-Wochen-Spanne:
$17.26
$25.80
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) Company Profile
Firmenname
Ishares Genomics Immunology And Healthcare Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie IDNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IDNA
Ishares Genomics Immunology And Healthcare Etf
|
20.94 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
304.36 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
617.97 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
620.94 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
241.31 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
547.16 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares Genomics Immunology And Healthcare Etf Aktie (IDNA) Neueste Nachrichten
(XDNA) Pivots Trading Plans and Risk Controls (XDNA:CA) - news.stocktradersdaily.com
(XDNA) Risk-Controlled Trading Report (XDNA:CA) - news.stocktradersdaily.com
Objective long/short (XDNA) Report (XDNA:CA) - news.stocktradersdaily.com
(XDNA) Trading Advice (XDNA:CA) - news.stocktradersdaily.com
Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal - Benzinga
(XDNA) Stock Trading Blueprint (XDNA:CA) - news.stocktradersdaily.com
Is Healthcare Losing the Status of Safe Haven? ETFs in Focus - Zacks Investment Research
Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion - Benzinga
IDNA: The Cutting Edge Of Medical Science Is A Risky Investment (NYSEARCA:IDNA) - Seeking Alpha
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The Perfect Storm? - Benzinga
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies - Benzinga
Future Health: Harnessing Innovations In Healthcare - Syfe
The Healthcare Sector: 5 Things To Know - Syfe
5 Best ETFs Tracking CRISPR Gene Editing - The Motley Fool
7 Best Biotech ETFs In Canada for March 2025 - Wealth Awesome
Has Biotechnology Bottomed Out? - Master Investor
3 Healthcare Technology Stocks to Improve Lives in 2024 - InvestorPlace
IDNA ETF: Continues To Underperform, But With Long Run Potential - Seeking Alpha
Megatrends: Gene Therapy and Editing - US News Money
StockWatch: Top Biotech ETFs (Mostly) Sink Faster than the Market During Q1 - Genetic Engineering and Biotechnology News
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector - InvestorPlace
3 Themes Growth and Tech Investors May Want to Consider in 2023 - Nasdaq
7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher - InvestorPlace
3 Biotech ETFs That Could Double Your Money by 2025 With Zero Effort - The Motley Fool
3 genome ETFs to watch in 2021 - CMC Markets
iShares Genomics Immunology And Healthcare ETF, Overshadowed But Not Irrelevant (NYSEARCA:IDNA) - Seeking Alpha
3 ETFs For More Moderna Bets - Yahoo
iShares Lists Cybersecurity and Genomics ETFs - ETF Trends
Top Healthcare ETFs Right Now • Updated Daily - Benzinga
Finanzdaten der Ishares Genomics Immunology And Healthcare Etf-Aktie (IDNA)
Es liegen keine Finanzdaten für Ishares Genomics Immunology And Healthcare Etf (IDNA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.26%
1.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):